# Intuitive Surgical timeline entity: /record/intuitive-surgical.md id: ent_intuitive-surgical Intuitive Surgical's timeline holds 599 claims from 2006 to 2026: 1 people, 590 money & deals, 8 other. 9 are undated. The latest took effect on October 15, 2026. Kinds: People 1 (/timelines/intuitive-surgical.md?kind=people) · Money & deals 590 (/timelines/intuitive-surgical.md?kind=money) · Products 0 (/timelines/intuitive-surgical.md?kind=products) · Models 0 (/timelines/intuitive-surgical.md?kind=models) · Other 8 (/timelines/intuitive-surgical.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2006 - 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 34,390,000 United States dollar | superseded | [clm_544FB518355D](/claim/clm_544FB518355D.md) - 2006-12-31 to 2007-12-31 | money | total_equity | 589,705,000 United States dollar | superseded | [clm_018CD0EF07C0](/claim/clm_018CD0EF07C0.md) ## 2007 - 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 122,825,000 United States dollar | superseded | [clm_82044DFC36A2](/claim/clm_82044DFC36A2.md) - 2007-12-31 to 2008-12-31 | money | net_income | 144,537,000 United States dollar | superseded | [clm_91FEB6C4031D](/claim/clm_91FEB6C4031D.md) - 2007-12-31 to 2008-12-31 | money | operating_income | 206,742,000 United States dollar | superseded | [clm_50200CC1EB24](/claim/clm_50200CC1EB24.md) - 2007-12-31 to 2008-12-31 | money | research_and_development | 48,859,000 United States dollar | superseded | [clm_23017B51ED4C](/claim/clm_23017B51ED4C.md) - 2007-12-31 to 2008-12-31 | money | revenue | 600,828,000 United States dollar | superseded | [clm_361F0564D015](/claim/clm_361F0564D015.md) - 2007-12-31 to 2008-12-31 | money | total_equity | 888,674,000 United States dollar | superseded | [clm_35A29C13B832](/claim/clm_35A29C13B832.md) ## 2008 - 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 223,023,000 United States dollar | superseded | [clm_7EC8517FBB25](/claim/clm_7EC8517FBB25.md) - 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 51,182,000 United States dollar | superseded | [clm_6941403BAC9E](/claim/clm_6941403BAC9E.md) - 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 78,195,000 United States dollar | superseded | [clm_8C133CA66855](/claim/clm_8C133CA66855.md) - 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 20,357,000 United States dollar | superseded | [clm_2E6E16E8C9BB](/claim/clm_2E6E16E8C9BB.md) - 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 219,189,000 United States dollar | superseded | [clm_0EFA86BCA89A](/claim/clm_0EFA86BCA89A.md) - 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 227,614,000 United States dollar | superseded | [clm_7714427E2A7A](/claim/clm_7714427E2A7A.md) - 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 57,594,000 United States dollar | superseded | [clm_37B3213FBC35](/claim/clm_37B3213FBC35.md) - 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 85,032,000 United States dollar | superseded | [clm_0ACCD182695A](/claim/clm_0ACCD182695A.md) - 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 21,851,000 United States dollar | superseded | [clm_BF86AD92E89D](/claim/clm_BF86AD92E89D.md) - 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 235,992,000 United States dollar | superseded | [clm_D4E252BEA47A](/claim/clm_D4E252BEA47A.md) - 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 194,623,000 United States dollar | superseded | [clm_3FF2954A0CC9](/claim/clm_3FF2954A0CC9.md) - 2008-12-31 to 2009-12-31 | money | net_income | 204,315,000 United States dollar | superseded | [clm_6525FBA9615B](/claim/clm_6525FBA9615B.md) - 2008-12-31 to 2009-12-31 | money | operating_income | 310,835,000 United States dollar | superseded | [clm_E6959903A10E](/claim/clm_E6959903A10E.md) - 2008-12-31 to 2009-12-31 | money | research_and_development | 79,372,000 United States dollar | superseded | [clm_244A5E2C7C56](/claim/clm_244A5E2C7C56.md) - 2008-12-31 to 2009-12-31 | money | revenue | 874,919,000 United States dollar | superseded | [clm_A045C1D7E978](/claim/clm_A045C1D7E978.md) - 2008-12-31 to 2009-06-30 | money | total_assets | 1,474,624,000 United States dollar | superseded | [clm_945E7216F7A8](/claim/clm_945E7216F7A8.md) - 2008-12-31 to 2009-06-30 | money | total_equity | 1,266,766,000 United States dollar | superseded | [clm_7537DCBDF9F7](/claim/clm_7537DCBDF9F7.md) ## 2009 - 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 96,600,000 United States dollar | superseded | [clm_BE8A7223F52E](/claim/clm_BE8A7223F52E.md) - 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 28,100,000 United States dollar | superseded | [clm_813BE8224F16](/claim/clm_813BE8224F16.md) - 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | 45,000,000 United States dollar | superseded | [clm_0922B64C0FB9](/claim/clm_0922B64C0FB9.md) - 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 21,300,000 United States dollar | superseded | [clm_D49A5BFD35EC](/claim/clm_D49A5BFD35EC.md) - 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 188,400,000 United States dollar | superseded | [clm_6BD0D44396A3](/claim/clm_6BD0D44396A3.md) - 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 173,421,000 United States dollar | superseded | [clm_179DE4C7BF7E](/claim/clm_179DE4C7BF7E.md) - 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 62,388,000 United States dollar | superseded | [clm_B9221A949FEA](/claim/clm_B9221A949FEA.md) - 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 99,540,000 United States dollar | superseded | [clm_843D99696217](/claim/clm_843D99696217.md) - 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 23,369,000 United States dollar | superseded | [clm_A6BB16C634EF](/claim/clm_A6BB16C634EF.md) - 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 260,624,000 United States dollar | superseded | [clm_A003ABCE770B](/claim/clm_A003ABCE770B.md) - 2009-06-30 to 2009-09-30 | money | total_assets | 1,501,282,000 United States dollar | superseded | [clm_33AAB7AAB5CC](/claim/clm_33AAB7AAB5CC.md) - 2009-06-30 to 2009-09-30 | money | total_equity | 1,271,184,000 United States dollar | superseded | [clm_2781956F5F2D](/claim/clm_2781956F5F2D.md) - 2009-07-17 to 2009-10-15 | money | shares_outstanding | 37,934,659 shares | superseded | [clm_99BB096921E7](/claim/clm_99BB096921E7.md) - 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 206,095,000 United States dollar | superseded | [clm_6919E0F81D19](/claim/clm_6919E0F81D19.md) - 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 64,524,000 United States dollar | superseded | [clm_BD68958D3723](/claim/clm_BD68958D3723.md) - 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | 104,491,000 United States dollar | superseded | [clm_CBCD5A4EF62C](/claim/clm_CBCD5A4EF62C.md) - 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 24,650,000 United States dollar | superseded | [clm_959969D20A6E](/claim/clm_959969D20A6E.md) - 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 280,134,000 United States dollar | superseded | [clm_EC171A20066A](/claim/clm_EC171A20066A.md) - 2009-09-30 to 2009-12-31 | money | total_assets | 1,637,811,000 United States dollar | superseded | [clm_750053ACF62D](/claim/clm_750053ACF62D.md) - 2009-09-30 to 2009-12-31 | money | total_equity | 1,390,262,000 United States dollar | superseded | [clm_429E7482A885](/claim/clm_429E7482A885.md) - 2009-10-15 to 2010-01-21 | money | shares_outstanding | 38,191,863 shares | superseded | [clm_F3E3CF153091](/claim/clm_F3E3CF153091.md) - 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 221,437,000 United States dollar | superseded | [clm_71EB711E9B8A](/claim/clm_71EB711E9B8A.md) - 2009-12-31 to 2010-12-31 | money | net_income | 232,606,000 United States dollar | superseded | [clm_A7FDD54280FB](/claim/clm_A7FDD54280FB.md) - 2009-12-31 to 2010-12-31 | money | operating_income | 377,439,000 United States dollar | superseded | [clm_674A7A92FFFF](/claim/clm_674A7A92FFFF.md) - 2009-12-31 to 2010-12-31 | money | research_and_development | 95,102,000 United States dollar | superseded | [clm_050827D8A51E](/claim/clm_050827D8A51E.md) - 2009-12-31 to 2010-12-31 | money | revenue | 1,052,168,000 United States dollar | superseded | [clm_AF328055BEF0](/claim/clm_AF328055BEF0.md) - 2009-12-31 to 2010-03-31 | money | total_assets | 1,809,716,000 United States dollar | superseded | [clm_F9E075264CEF](/claim/clm_F9E075264CEF.md) - 2009-12-31 to 2010-03-31 | money | total_equity | 1,537,283,000 United States dollar | superseded | [clm_613FBBE0482A](/claim/clm_613FBBE0482A.md) ## 2010 - 2010-01-21 to 2010-04-15 | money | shares_outstanding | 38,504,605 shares | superseded | [clm_FEE23498EFC6](/claim/clm_FEE23498EFC6.md) - 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 313,600,000 United States dollar | superseded | [clm_822BC912B1EC](/claim/clm_822BC912B1EC.md) - 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 85,300,000 United States dollar | superseded | [clm_7723C8E66225](/claim/clm_7723C8E66225.md) - 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 129,700,000 United States dollar | superseded | [clm_66C44CA0F3A0](/claim/clm_66C44CA0F3A0.md) - 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 28,000,000 United States dollar | superseded | [clm_FC5425BEAE51](/claim/clm_FC5425BEAE51.md) - 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 328,600,000 United States dollar | superseded | [clm_D1A95C9B4473](/claim/clm_D1A95C9B4473.md) - 2010-03-31 to 2010-06-30 | money | total_assets | 2,016,600,000 United States dollar | superseded | [clm_AF900C813E63](/claim/clm_AF900C813E63.md) - 2010-03-31 to 2010-06-30 | money | total_equity | 1,770,000,000 United States dollar | superseded | [clm_C6C2953DDD31](/claim/clm_C6C2953DDD31.md) - 2010-04-15 to 2010-07-12 | money | shares_outstanding | 39,166,066 shares | superseded | [clm_A328A8EDA389](/claim/clm_A328A8EDA389.md) - 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 420,000,000 United States dollar | superseded | [clm_3E3309604F17](/claim/clm_3E3309604F17.md) - 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 88,700,000 United States dollar | superseded | [clm_8E9C5B36C8CD](/claim/clm_8E9C5B36C8CD.md) - 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 139,700,000 United States dollar | superseded | [clm_35A1E8D0C3B9](/claim/clm_35A1E8D0C3B9.md) - 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 28,500,000 United States dollar | superseded | [clm_0F3BFE76C9C2](/claim/clm_0F3BFE76C9C2.md) - 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 350,700,000 United States dollar | superseded | [clm_47AADA874A29](/claim/clm_47AADA874A29.md) - 2010-06-30 to 2010-09-30 | money | total_assets | 2,243,100,000 United States dollar | superseded | [clm_E7FCDE14B582](/claim/clm_E7FCDE14B582.md) - 2010-06-30 to 2010-09-30 | money | total_equity | 1,924,400,000 United States dollar | superseded | [clm_EFB0DCB105CB](/claim/clm_EFB0DCB105CB.md) - 2010-07-12 to 2010-10-08 | money | shares_outstanding | 39,352,498 shares | superseded | [clm_8B2D85549A7C](/claim/clm_8B2D85549A7C.md) - 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 382,000,000 United States dollar | superseded | [clm_44679F17E2E6](/claim/clm_44679F17E2E6.md) - 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 86,600,000 United States dollar | superseded | [clm_30B8898F1BB8](/claim/clm_30B8898F1BB8.md) - 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 132,100,000 United States dollar | superseded | [clm_E528C013C797](/claim/clm_E528C013C797.md) - 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 26,900,000 United States dollar | superseded | [clm_CF5153B4C341](/claim/clm_CF5153B4C341.md) - 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 344,400,000 United States dollar | superseded | [clm_0785418FE2FD](/claim/clm_0785418FE2FD.md) - 2010-09-30 to 2010-12-31 | money | total_assets | 2,351,800,000 United States dollar | superseded | [clm_3C99CBBF2246](/claim/clm_3C99CBBF2246.md) - 2010-09-30 to 2010-12-31 | money | total_equity | 2,008,300,000 United States dollar | superseded | [clm_BFC23EFDB51A](/claim/clm_BFC23EFDB51A.md) - 2010-10-08 to 2011-01-20 | money | shares_outstanding | 39,293,400 shares | superseded | [clm_168A55184D50](/claim/clm_168A55184D50.md) - 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 279,800,000 United States dollar | superseded | [clm_7591C0809487](/claim/clm_7591C0809487.md) - 2010-12-31 to 2011-12-31 | money | net_income | 381,800,000 United States dollar | superseded | [clm_459A20FF7D0C](/claim/clm_459A20FF7D0C.md) - 2010-12-31 to 2011-12-31 | money | operating_income | 555,200,000 United States dollar | superseded | [clm_E517CB36ED13](/claim/clm_E517CB36ED13.md) - 2010-12-31 to 2011-12-31 | money | research_and_development | 116,000,000 United States dollar | superseded | [clm_69B48733B77C](/claim/clm_69B48733B77C.md) - 2010-12-31 to 2011-12-31 | money | revenue | 1,413,000,000 United States dollar | superseded | [clm_0CB446352503](/claim/clm_0CB446352503.md) - 2010-12-31 to 2011-03-31 | money | total_assets | 2,390,400,000 United States dollar | superseded | [clm_19D562461FE3](/claim/clm_19D562461FE3.md) - 2010-12-31 to 2011-03-31 | money | total_equity | 2,037,400,000 United States dollar | superseded | [clm_784DEE500983](/claim/clm_784DEE500983.md) ## 2011 - 2011-01-20 to 2011-04-15 | money | shares_outstanding | 38,866,512 shares | superseded | [clm_398FF61A259C](/claim/clm_398FF61A259C.md) - 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 449,800,000 United States dollar | superseded | [clm_63A4046D9016](/claim/clm_63A4046D9016.md) - 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 104,100,000 United States dollar | superseded | [clm_4964BE38E7DD](/claim/clm_4964BE38E7DD.md) - 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 148,300,000 United States dollar | superseded | [clm_266B5C9D71EA](/claim/clm_266B5C9D71EA.md) - 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 31,400,000 United States dollar | superseded | [clm_460C1EB5B256](/claim/clm_460C1EB5B256.md) - 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 388,100,000 United States dollar | superseded | [clm_6A505DEA7C4E](/claim/clm_6A505DEA7C4E.md) - 2011-03-31 to 2011-06-30 | money | total_assets | 2,568,300,000 United States dollar | superseded | [clm_40812385FDD0](/claim/clm_40812385FDD0.md) - 2011-03-31 to 2011-06-30 | money | total_equity | 2,230,900,000 United States dollar | superseded | [clm_7678A4B2748D](/claim/clm_7678A4B2748D.md) - 2011-04-15 to 2011-07-14 | money | shares_outstanding | 39,287,961 shares | superseded | [clm_2E63DF25C776](/claim/clm_2E63DF25C776.md) - 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 382,000,000 United States dollar | superseded | [clm_0CB9F9C99710](/claim/clm_0CB9F9C99710.md) - 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 117,400,000 United States dollar | superseded | [clm_1CD472C8B77F](/claim/clm_1CD472C8B77F.md) - 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 168,100,000 United States dollar | superseded | [clm_8DBC05B747AB](/claim/clm_8DBC05B747AB.md) - 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 32,000,000 United States dollar | superseded | [clm_1C887115BAC0](/claim/clm_1C887115BAC0.md) - 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 425,700,000 United States dollar | superseded | [clm_1DA05C3763DB](/claim/clm_1DA05C3763DB.md) - 2011-06-30 to 2011-09-30 | money | total_assets | 2,649,900,000 United States dollar | superseded | [clm_6347016B4038](/claim/clm_6347016B4038.md) - 2011-06-30 to 2011-09-30 | money | total_equity | 2,288,500,000 United States dollar | superseded | [clm_C9E0AB9A4E7E](/claim/clm_C9E0AB9A4E7E.md) - 2011-07-14 to 2011-10-13 | money | shares_outstanding | 39,083,127 shares | superseded | [clm_C63A08DDFD0C](/claim/clm_C63A08DDFD0C.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 298,200,000 United States dollar | superseded | [clm_C92E68D633E1](/claim/clm_C92E68D633E1.md) - 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 122,400,000 United States dollar | superseded | [clm_D86F51287293](/claim/clm_D86F51287293.md) - 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 178,900,000 United States dollar | superseded | [clm_8A8C3D8CBC84](/claim/clm_8A8C3D8CBC84.md) - 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 35,400,000 United States dollar | superseded | [clm_47F197914C85](/claim/clm_47F197914C85.md) - 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 446,700,000 United States dollar | superseded | [clm_3CB90203D921](/claim/clm_3CB90203D921.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 2,746,000,000 United States dollar | superseded | [clm_7DF7D34D8D51](/claim/clm_7DF7D34D8D51.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 2,369,000,000 United States dollar | superseded | [clm_ED6D6F35233A](/claim/clm_ED6D6F35233A.md) - 2011-10-13 to 2012-01-20 | money | shares_outstanding | 38,994,233 shares | superseded | [clm_7B7F3314257F](/claim/clm_7B7F3314257F.md) - 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 465,800,000 United States dollar | superseded | [clm_A4862C46637A](/claim/clm_A4862C46637A.md) - 2011-12-31 to 2012-12-31 | money | net_income | 495,100,000 United States dollar | superseded | [clm_D81C58D46387](/claim/clm_D81C58D46387.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 694,800,000 United States dollar | superseded | [clm_408B57D0C290](/claim/clm_408B57D0C290.md) - 2011-12-31 to 2012-12-31 | money | research_and_development | 140,200,000 United States dollar | superseded | [clm_3A748C8AD5F9](/claim/clm_3A748C8AD5F9.md) - 2011-12-31 to 2012-12-31 | money | revenue | 1,757,300,000 United States dollar | superseded | [clm_8898ADA48C34](/claim/clm_8898ADA48C34.md) - 2011-12-31 to 2012-03-31 | money | total_assets | 3,063,100,000 United States dollar | superseded | [clm_6374279DF7C8](/claim/clm_6374279DF7C8.md) - 2011-12-31 to 2012-03-31 | money | total_equity | 2,645,600,000 United States dollar | superseded | [clm_5225BA5BA5C8](/claim/clm_5225BA5BA5C8.md) ## 2012 - 2012-01-20 to 2012-04-13 | money | shares_outstanding | 39,346,384 shares | superseded | [clm_D48902C97850](/claim/clm_D48902C97850.md) - 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 325,900,000 United States dollar | superseded | [clm_243A37566C79](/claim/clm_243A37566C79.md) - 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 143,500,000 United States dollar | superseded | [clm_94A30D4CFAE9](/claim/clm_94A30D4CFAE9.md) - 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 193,300,000 United States dollar | superseded | [clm_E228EBABD06C](/claim/clm_E228EBABD06C.md) - 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 38,400,000 United States dollar | superseded | [clm_C8F6CFC7F1C2](/claim/clm_C8F6CFC7F1C2.md) - 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 495,200,000 United States dollar | superseded | [clm_B05591C4688A](/claim/clm_B05591C4688A.md) - 2012-03-31 to 2012-06-30 | money | total_assets | 3,332,900,000 United States dollar | superseded | [clm_0DCFC2FEB43E](/claim/clm_0DCFC2FEB43E.md) - 2012-03-31 to 2012-06-30 | money | total_equity | 2,927,300,000 United States dollar | superseded | [clm_8964D22D38F5](/claim/clm_8964D22D38F5.md) - 2012-04-13 to 2012-07-16 | money | shares_outstanding | 39,702,301 shares | superseded | [clm_9FFA51356F44](/claim/clm_9FFA51356F44.md) - 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 484,400,000 United States dollar | superseded | [clm_B4A99F709CF1](/claim/clm_B4A99F709CF1.md) - 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 154,900,000 United States dollar | superseded | [clm_7A0D6A76B907](/claim/clm_7A0D6A76B907.md) - 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 225,300,000 United States dollar | superseded | [clm_0FCEEFA8B963](/claim/clm_0FCEEFA8B963.md) - 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 40,200,000 United States dollar | superseded | [clm_C7CF1B957F3B](/claim/clm_C7CF1B957F3B.md) - 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 536,500,000 United States dollar | superseded | [clm_ACA384C54447](/claim/clm_ACA384C54447.md) - 2012-06-30 to 2012-09-30 | money | total_assets | 3,626,100,000 United States dollar | superseded | [clm_18CECB497650](/claim/clm_18CECB497650.md) - 2012-06-30 to 2012-09-30 | money | total_equity | 3,182,400,000 United States dollar | superseded | [clm_B6B1959AA8E2](/claim/clm_B6B1959AA8E2.md) - 2012-07-16 to 2012-10-10 | money | shares_outstanding | 39,934,128 shares | superseded | [clm_2FEAE536D4A9](/claim/clm_2FEAE536D4A9.md) - 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 396,200,000 United States dollar | superseded | [clm_4032E20330AF](/claim/clm_4032E20330AF.md) - 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 183,300,000 United States dollar | superseded | [clm_5EF6D7A75B14](/claim/clm_5EF6D7A75B14.md) - 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 211,400,000 United States dollar | superseded | [clm_BBB970B6A3F9](/claim/clm_BBB970B6A3F9.md) - 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 49,700,000 United States dollar | superseded | [clm_6B413D09C7C1](/claim/clm_6B413D09C7C1.md) - 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 537,800,000 United States dollar | superseded | [clm_13F0F8B315EA](/claim/clm_13F0F8B315EA.md) - 2012-09-30 to 2012-12-31 | money | total_assets | 3,732,200,000 United States dollar | superseded | [clm_8C4784FBDEB6](/claim/clm_8C4784FBDEB6.md) - 2012-09-30 to 2012-12-31 | money | total_equity | 3,293,500,000 United States dollar | superseded | [clm_3C3138CFFC02](/claim/clm_3C3138CFFC02.md) - 2012-10-10 to 2013-01-18 | money | shares_outstanding | 39,763,191 shares | superseded | [clm_AB1C7B411D3E](/claim/clm_AB1C7B411D3E.md) - 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 553,700,000 United States dollar | superseded | [clm_6E614B346FA1](/claim/clm_6E614B346FA1.md) - 2012-12-31 to 2013-12-31 | money | net_income | 656,600,000 United States dollar | superseded | [clm_F0E5C6C69FDA](/claim/clm_F0E5C6C69FDA.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 878,100,000 United States dollar | superseded | [clm_7FDE8A96A54C](/claim/clm_7FDE8A96A54C.md) - 2012-12-31 to 2013-12-31 | money | research_and_development | 170,000,000 United States dollar | superseded | [clm_2A59B0E1BFA3](/claim/clm_2A59B0E1BFA3.md) - 2012-12-31 to 2013-12-31 | money | revenue | 2,178,800,000 United States dollar | superseded | [clm_612B1A2DAE3C](/claim/clm_612B1A2DAE3C.md) - 2012-12-31 to 2013-03-31 | money | total_assets | 4,059,200,000 United States dollar | superseded | [clm_43CE9BDC7EAB](/claim/clm_43CE9BDC7EAB.md) - 2012-12-31 to 2013-03-31 | money | total_equity | 3,580,100,000 United States dollar | superseded | [clm_0BA6B620ACD6](/claim/clm_0BA6B620ACD6.md) ## 2013 - 2013-01-18 to 2013-04-10 | money | shares_outstanding | 40,127,042 shares | superseded | [clm_E2362664041D](/claim/clm_E2362664041D.md) - 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 427,500,000 United States dollar | superseded | [clm_B00404D41512](/claim/clm_B00404D41512.md) - 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 188,900,000 United States dollar | superseded | [clm_BDA7C6BFDD04](/claim/clm_BDA7C6BFDD04.md) - 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 251,200,000 United States dollar | superseded | [clm_C255F2AF7468](/claim/clm_C255F2AF7468.md) - 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 41,600,000 United States dollar | superseded | [clm_F4EAE57CDC96](/claim/clm_F4EAE57CDC96.md) - 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 611,400,000 United States dollar | superseded | [clm_474694B84A1D](/claim/clm_474694B84A1D.md) - 2013-03-31 to 2013-06-30 | money | total_assets | 4,235,800,000 United States dollar | superseded | [clm_E7AF51B9D09F](/claim/clm_E7AF51B9D09F.md) - 2013-03-31 to 2013-06-30 | money | total_equity | 3,772,200,000 United States dollar | superseded | [clm_A94D2B40E44F](/claim/clm_A94D2B40E44F.md) - 2013-04-10 to 2013-07-10 | money | shares_outstanding | 40,161,022 shares | superseded | [clm_2E0C05667D64](/claim/clm_2E0C05667D64.md) - 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 432,700,000 United States dollar | superseded | [clm_BB32146EF253](/claim/clm_BB32146EF253.md) - 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 159,100,000 United States dollar | superseded | [clm_B454945A8784](/claim/clm_B454945A8784.md) - 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 218,500,000 United States dollar | superseded | [clm_9F8A26CEC26C](/claim/clm_9F8A26CEC26C.md) - 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 41,200,000 United States dollar | superseded | [clm_3EFE58446F62](/claim/clm_3EFE58446F62.md) - 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 578,500,000 United States dollar | superseded | [clm_C8811BD79DD8](/claim/clm_C8811BD79DD8.md) - 2013-06-30 to 2013-09-30 | money | total_assets | 4,201,300,000 United States dollar | superseded | [clm_E30FC6197DD8](/claim/clm_E30FC6197DD8.md) - 2013-06-30 to 2013-09-30 | money | total_equity | 3,718,800,000 United States dollar | superseded | [clm_E1D0E1CF61ED](/claim/clm_E1D0E1CF61ED.md) - 2013-07-10 to 2013-10-08 | money | shares_outstanding | 39,709,905 shares | superseded | [clm_E54480B253F9](/claim/clm_E54480B253F9.md) - 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 586,800,000 United States dollar | superseded | [clm_3181D5A845EB](/claim/clm_3181D5A845EB.md) - 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 156,800,000 United States dollar | superseded | [clm_6545DE741A76](/claim/clm_6545DE741A76.md) - 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 174,200,000 United States dollar | superseded | [clm_BD36F287E05F](/claim/clm_BD36F287E05F.md) - 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 43,200,000 United States dollar | superseded | [clm_0D7D40944D61](/claim/clm_0D7D40944D61.md) - 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 499,000,000 United States dollar | superseded | [clm_B976A70F98C3](/claim/clm_B976A70F98C3.md) - 2013-09-30 to 2013-12-31 | money | total_assets | 3,697,400,000 United States dollar | superseded | [clm_05A4670EAE53](/claim/clm_05A4670EAE53.md) - 2013-09-30 to 2013-12-31 | money | total_equity | 3,264,300,000 United States dollar | superseded | [clm_D5E57BAEDBC5](/claim/clm_D5E57BAEDBC5.md) - 2013-10-08 to 2014-01-17 | money | shares_outstanding | 38,064,183 shares | superseded | [clm_E024CA667806](/claim/clm_E024CA667806.md) - 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 782,100,000 United States dollar | superseded | [clm_E278C1F0BC21](/claim/clm_E278C1F0BC21.md) - 2013-12-31 to 2014-12-31 | money | net_income | 671,000,000 United States dollar | superseded | [clm_668D0FBC0308](/claim/clm_668D0FBC0308.md) - 2013-12-31 to 2014-12-31 | money | operating_income | 852,500,000 United States dollar | superseded | [clm_7A52D8A8F8EA](/claim/clm_7A52D8A8F8EA.md) - 2013-12-31 to 2014-12-31 | money | research_and_development | 167,700,000 United States dollar | superseded | [clm_299F8020E15B](/claim/clm_299F8020E15B.md) - 2013-12-31 to 2014-12-31 | money | revenue | 2,265,100,000 United States dollar | superseded | [clm_94E8A3A20C8E](/claim/clm_94E8A3A20C8E.md) - 2013-12-31 to 2014-03-31 | money | total_assets | 3,950,300,000 United States dollar | superseded | [clm_D6AE030905B3](/claim/clm_D6AE030905B3.md) - 2013-12-31 to 2014-03-31 | money | total_equity | 3,501,400,000 United States dollar | superseded | [clm_C0A87CB3D8D1](/claim/clm_C0A87CB3D8D1.md) ## 2014 - 2014-01-17 to 2014-04-14 | money | shares_outstanding | 38,171,349 shares | superseded | [clm_E308A9EE27C7](/claim/clm_E308A9EE27C7.md) - 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 814,000,000 United States dollar | superseded | [clm_4436719B69A1](/claim/clm_4436719B69A1.md) - 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 44,300,000 United States dollar | superseded | [clm_6302EE9CE91F](/claim/clm_6302EE9CE91F.md) - 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 56,600,000 United States dollar | superseded | [clm_CF2F19D15000](/claim/clm_CF2F19D15000.md) - 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 43,000,000 United States dollar | superseded | [clm_719162ADA0CA](/claim/clm_719162ADA0CA.md) - 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 464,700,000 United States dollar | superseded | [clm_556C9F80BBAF](/claim/clm_556C9F80BBAF.md) - 2014-03-31 to 2014-06-30 | money | total_assets | 4,194,200,000 United States dollar | superseded | [clm_5041452C303A](/claim/clm_5041452C303A.md) - 2014-03-31 to 2014-06-30 | money | total_equity | 3,656,600,000 United States dollar | superseded | [clm_A79B863D29BB](/claim/clm_A79B863D29BB.md) - 2014-04-14 to 2014-07-14 | money | shares_outstanding | 38,403,653 shares | superseded | [clm_C7CCDA70D7A7](/claim/clm_C7CCDA70D7A7.md) - 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 507,600,000 United States dollar | superseded | [clm_2A428684FD9A](/claim/clm_2A428684FD9A.md) - 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 104,000,000 United States dollar | superseded | [clm_680BE5673DF2](/claim/clm_680BE5673DF2.md) - 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 143,000,000 United States dollar | superseded | [clm_C9BECC11D231](/claim/clm_C9BECC11D231.md) - 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 40,200,000 United States dollar | superseded | [clm_5D2248336E37](/claim/clm_5D2248336E37.md) - 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 512,200,000 United States dollar | superseded | [clm_56EBD3FA995C](/claim/clm_56EBD3FA995C.md) - 2014-06-30 to 2014-09-30 | money | total_assets | 3,404,600,000 United States dollar | superseded | [clm_7BE317B294D5](/claim/clm_7BE317B294D5.md) - 2014-06-30 to 2014-09-30 | money | total_equity | 2,822,400,000 United States dollar | superseded | [clm_958E69E69DA8](/claim/clm_958E69E69DA8.md) - 2014-07-14 to 2014-10-13 | money | shares_outstanding | 35,951,604 shares | superseded | [clm_85111C2A1AE1](/claim/clm_85111C2A1AE1.md) - 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 493,000,000 United States dollar | superseded | [clm_6B2138E0659C](/claim/clm_6B2138E0659C.md) - 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 123,700,000 United States dollar | superseded | [clm_5CDB778466E2](/claim/clm_5CDB778466E2.md) - 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 159,100,000 United States dollar | superseded | [clm_839B35C3BBB6](/claim/clm_839B35C3BBB6.md) - 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 47,500,000 United States dollar | superseded | [clm_510F3199D93C](/claim/clm_510F3199D93C.md) - 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 550,100,000 United States dollar | superseded | [clm_147B68E634BD](/claim/clm_147B68E634BD.md) - 2014-09-30 to 2014-12-31 | money | total_assets | 3,651,500,000 United States dollar | superseded | [clm_E14CA52179E3](/claim/clm_E14CA52179E3.md) - 2014-09-30 to 2014-12-31 | money | total_equity | 3,084,200,000 United States dollar | superseded | [clm_D2D8EE8EBB4A](/claim/clm_D2D8EE8EBB4A.md) - 2014-10-13 to 2015-01-16 | money | shares_outstanding | 36,251,945 shares | superseded | [clm_2FC505E298AA](/claim/clm_2FC505E298AA.md) - 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 600,300,000 United States dollar | superseded | [clm_B1FBB34E41AE](/claim/clm_B1FBB34E41AE.md) - 2014-12-31 to 2015-12-31 | money | net_income | 418,800,000 United States dollar | superseded | [clm_8F7131569537](/claim/clm_8F7131569537.md) - 2014-12-31 to 2015-12-31 | money | operating_income | 544,800,000 United States dollar | superseded | [clm_EB957F4CF3D9](/claim/clm_EB957F4CF3D9.md) - 2014-12-31 to 2015-12-31 | money | research_and_development | 178,000,000 United States dollar | superseded | [clm_9E069CBDD650](/claim/clm_9E069CBDD650.md) - 2014-12-31 to 2015-12-31 | money | revenue | 2,131,700,000 United States dollar | superseded | [clm_DA4A75A5DC92](/claim/clm_DA4A75A5DC92.md) - 2014-12-31 to 2015-03-31 | money | total_assets | 3,959,400,000 United States dollar | superseded | [clm_11298F499B8E](/claim/clm_11298F499B8E.md) - 2014-12-31 to 2015-03-31 | money | total_equity | 3,379,400,000 United States dollar | superseded | [clm_C9739D9F26F4](/claim/clm_C9739D9F26F4.md) ## 2015 - 2015-01-16 to 2015-04-17 | money | shares_outstanding | 36,599,799 shares | superseded | [clm_62DD035FA7C0](/claim/clm_62DD035FA7C0.md) - 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 701,100,000 United States dollar | superseded | [clm_0FAFC2C7E7D8](/claim/clm_0FAFC2C7E7D8.md) - 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 97,000,000 United States dollar | superseded | [clm_F0985729C7AA](/claim/clm_F0985729C7AA.md) - 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 130,400,000 United States dollar | superseded | [clm_387B18C15AFD](/claim/clm_387B18C15AFD.md) - 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 44,400,000 United States dollar | superseded | [clm_001864115817](/claim/clm_001864115817.md) - 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 532,100,000 United States dollar | superseded | [clm_8D2C36F50D45](/claim/clm_8D2C36F50D45.md) - 2015-03-31 to 2015-06-30 | money | total_assets | 4,126,200,000 United States dollar | superseded | [clm_04006D246945](/claim/clm_04006D246945.md) - 2015-03-31 to 2015-06-30 | money | total_equity | 3,585,400,000 United States dollar | superseded | [clm_41E9AE78AD26](/claim/clm_41E9AE78AD26.md) - 2015-04-17 to 2015-07-16 | money | shares_outstanding | 36,858,015 shares | superseded | [clm_B1EDC2F01335](/claim/clm_B1EDC2F01335.md) - 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 915,400,000 United States dollar | superseded | [clm_B2D4B422EFA9](/claim/clm_B2D4B422EFA9.md) - 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 134,500,000 United States dollar | superseded | [clm_5A83469A8295](/claim/clm_5A83469A8295.md) - 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 173,800,000 United States dollar | superseded | [clm_2465B3D64FAE](/claim/clm_2465B3D64FAE.md) - 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 49,400,000 United States dollar | superseded | [clm_276F8AFB81AB](/claim/clm_276F8AFB81AB.md) - 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 586,100,000 United States dollar | superseded | [clm_BFB7A48A1E2B](/claim/clm_BFB7A48A1E2B.md) - 2015-06-30 to 2015-09-30 | money | total_assets | 4,354,500,000 United States dollar | superseded | [clm_C0C937DBE9FB](/claim/clm_C0C937DBE9FB.md) - 2015-06-30 to 2015-09-30 | money | total_equity | 3,792,700,000 United States dollar | superseded | [clm_7C329A0292EA](/claim/clm_7C329A0292EA.md) - 2015-07-16 to 2015-10-15 | money | shares_outstanding | 37,019,120 shares | superseded | [clm_6EC140E34D62](/claim/clm_6EC140E34D62.md) - 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 868,200,000 United States dollar | superseded | [clm_98872233432F](/claim/clm_98872233432F.md) - 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 167,300,000 United States dollar | superseded | [clm_08FE8C95D857](/claim/clm_08FE8C95D857.md) - 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 189,900,000 United States dollar | superseded | [clm_78491C5493A1](/claim/clm_78491C5493A1.md) - 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 51,000,000 United States dollar | superseded | [clm_7EFC4CEE6245](/claim/clm_7EFC4CEE6245.md) - 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 589,700,000 United States dollar | superseded | [clm_0726B6C5A3AD](/claim/clm_0726B6C5A3AD.md) - 2015-09-30 to 2015-12-31 | money | total_assets | 4,682,300,000 United States dollar | superseded | [clm_DD84F38F8F1A](/claim/clm_DD84F38F8F1A.md) - 2015-09-30 to 2015-12-31 | money | total_equity | 4,115,200,000 United States dollar | superseded | [clm_1C14F219156B](/claim/clm_1C14F219156B.md) - 2015-10-15 to 2016-01-19 | money | shares_outstanding | 37,365,210 shares | superseded | [clm_385065A14A8B](/claim/clm_385065A14A8B.md) - 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 714,600,000 United States dollar | superseded | [clm_2D47D1C60ABD](/claim/clm_2D47D1C60ABD.md) - 2015-12-31 to 2016-12-31 | money | net_income | 588,800,000 United States dollar | superseded | [clm_A98095BD2204](/claim/clm_A98095BD2204.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 740,000,000 United States dollar | superseded | [clm_F2395161998C](/claim/clm_F2395161998C.md) - 2015-12-31 to 2016-12-31 | money | research_and_development | 197,400,000 United States dollar | superseded | [clm_21DC0AB26609](/claim/clm_21DC0AB26609.md) - 2015-12-31 to 2016-12-31 | money | revenue | 2,384,400,000 United States dollar | superseded | [clm_C8BE679C8EB6](/claim/clm_C8BE679C8EB6.md) - 2015-12-31 to 2016-03-31 | money | total_assets | 4,907,300,000 United States dollar | superseded | [clm_1D039DE17140](/claim/clm_1D039DE17140.md) - 2015-12-31 to 2016-03-31 | money | total_equity | 4,319,500,000 United States dollar | superseded | [clm_6379C086BF73](/claim/clm_6379C086BF73.md) ## 2016 - 2016-01-19 to 2016-04-15 | money | shares_outstanding | 37,380,279 shares | superseded | [clm_0FDD9669E0C2](/claim/clm_0FDD9669E0C2.md) - 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 980,500,000 United States dollar | superseded | [clm_9DB9F96AA986](/claim/clm_9DB9F96AA986.md) - 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 136,400,000 United States dollar | superseded | [clm_9548F5F21CE8](/claim/clm_9548F5F21CE8.md) - 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 179,000,000 United States dollar | superseded | [clm_DAB65AA680DC](/claim/clm_DAB65AA680DC.md) - 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 53,200,000 United States dollar | superseded | [clm_BA99D48B59A6](/claim/clm_BA99D48B59A6.md) - 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 594,500,000 United States dollar | superseded | [clm_D3821E417CD1](/claim/clm_D3821E417CD1.md) - 2016-03-31 to 2016-06-30 | money | total_assets | 5,306,300,000 United States dollar | superseded | [clm_40B22DF97E69](/claim/clm_40B22DF97E69.md) - 2016-03-31 to 2016-06-30 | money | total_equity | 4,750,400,000 United States dollar | superseded | [clm_B76D1381A5A8](/claim/clm_B76D1381A5A8.md) - 2016-04-15 to 2016-07-15 | money | shares_outstanding | 38,060,364 shares | superseded | [clm_35CFD8D26508](/claim/clm_35CFD8D26508.md) - 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 1,193,500,000 United States dollar | superseded | [clm_183ADE62076E](/claim/clm_183ADE62076E.md) - 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 184,500,000 United States dollar | superseded | [clm_C0BCA5D89C28](/claim/clm_C0BCA5D89C28.md) - 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 245,400,000 United States dollar | superseded | [clm_043157E1C4D7](/claim/clm_043157E1C4D7.md) - 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 54,700,000 United States dollar | superseded | [clm_A3F193F4B5DB](/claim/clm_A3F193F4B5DB.md) - 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 670,100,000 United States dollar | superseded | [clm_D83E4C623017](/claim/clm_D83E4C623017.md) - 2016-06-30 to 2016-09-30 | money | total_assets | 5,780,800,000 United States dollar | superseded | [clm_1B48B5604BC4](/claim/clm_1B48B5604BC4.md) - 2016-06-30 to 2016-09-30 | money | total_equity | 5,181,500,000 United States dollar | superseded | [clm_42B9D90D7D5F](/claim/clm_42B9D90D7D5F.md) - 2016-07-15 to 2016-10-13 | money | shares_outstanding | 38,493,364 shares | superseded | [clm_14D88EE6373B](/claim/clm_14D88EE6373B.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 1,021,600,000 United States dollar | superseded | [clm_2F41478CD09E](/claim/clm_2F41478CD09E.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 211,000,000 United States dollar | superseded | [clm_5EFCF078DCFF](/claim/clm_5EFCF078DCFF.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 256,400,000 United States dollar | superseded | [clm_7B7D0CF2907A](/claim/clm_7B7D0CF2907A.md) - 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 62,600,000 United States dollar | superseded | [clm_1EFBB23330FC](/claim/clm_1EFBB23330FC.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 682,900,000 United States dollar | superseded | [clm_906C93F59F7B](/claim/clm_906C93F59F7B.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 6,174,700,000 United States dollar | superseded | [clm_FD06802F2B2B](/claim/clm_FD06802F2B2B.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 5,541,800,000 United States dollar | superseded | [clm_F224E9B2A3EC](/claim/clm_F224E9B2A3EC.md) - 2016-10-13 to 2017-01-20 | money | shares_outstanding | 38,747,011 shares | superseded | [clm_A0FB75D3B9EA](/claim/clm_A0FB75D3B9EA.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 1,036,600,000 United States dollar | superseded | [clm_7DEAE73EA1A9](/claim/clm_7DEAE73EA1A9.md) - 2016-12-31 to 2017-12-31 | money | net_income | 735,900,000 United States dollar | superseded | [clm_22B3B83343CC](/claim/clm_22B3B83343CC.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 945,200,000 United States dollar | superseded | [clm_374F408FAE71](/claim/clm_374F408FAE71.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 239,600,000 United States dollar | superseded | [clm_B0EF0F1AE775](/claim/clm_B0EF0F1AE775.md) - 2016-12-31 to 2017-12-31 | money | revenue | 2,706,500,000 United States dollar | superseded | [clm_E30042DF7209](/claim/clm_E30042DF7209.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 6,486,900,000 United States dollar | superseded | [clm_EC4551D21C5F](/claim/clm_EC4551D21C5F.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 5,777,800,000 United States dollar | superseded | [clm_60412C27EF7E](/claim/clm_60412C27EF7E.md) ## 2017 - 2017-01-20 to 2017-04-14 | money | shares_outstanding | 38,786,979 shares | superseded | [clm_ADCFEDA3D374](/claim/clm_ADCFEDA3D374.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 708,600,000 United States dollar | superseded | [clm_E0382654C54F](/claim/clm_E0382654C54F.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 179,800,000 United States dollar | superseded | [clm_8915A591DF23](/claim/clm_8915A591DF23.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 191,500,000 United States dollar | superseded | [clm_E82AC3068ACC](/claim/clm_E82AC3068ACC.md) - 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 73,500,000 United States dollar | superseded | [clm_EEBF9BEED615](/claim/clm_EEBF9BEED615.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 679,600,000 United States dollar | superseded | [clm_90905577F222](/claim/clm_90905577F222.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 4,808,000,000 United States dollar | superseded | [clm_5A275CC493D2](/claim/clm_5A275CC493D2.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 4,127,500,000 United States dollar | superseded | [clm_F1ECF39E4D3A](/claim/clm_F1ECF39E4D3A.md) - 2017-04-14 to 2017-07-18 | money | shares_outstanding | 36,840,763 shares | superseded | [clm_3223B2BA32A9](/claim/clm_3223B2BA32A9.md) - 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 696,500,000 United States dollar | superseded | [clm_9999380DD03F](/claim/clm_9999380DD03F.md) - 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 221,500,000 United States dollar | superseded | [clm_52594A9FC746](/claim/clm_52594A9FC746.md) - 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 257,500,000 United States dollar | superseded | [clm_988F893981AC](/claim/clm_988F893981AC.md) - 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 84,600,000 United States dollar | superseded | [clm_4AAEE516B289](/claim/clm_4AAEE516B289.md) - 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 758,800,000 United States dollar | superseded | [clm_A0DE38A07335](/claim/clm_A0DE38A07335.md) - 2017-06-30 to 2017-09-30 | money | total_assets | 5,250,800,000 United States dollar | superseded | [clm_66327F5596DF](/claim/clm_66327F5596DF.md) - 2017-06-30 to 2017-09-30 | money | total_equity | 4,522,300,000 United States dollar | superseded | [clm_EF5FBFFD5F3D](/claim/clm_EF5FBFFD5F3D.md) - 2017-07-18 to 2017-10-17 | money | shares_outstanding | 37,150,987 shares | superseded | [clm_37294DFDA16A](/claim/clm_37294DFDA16A.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 875,000,000 United States dollar | superseded | [clm_C8575861FEFF](/claim/clm_C8575861FEFF.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 297,500,000 United States dollar | superseded | [clm_0F401287951C](/claim/clm_0F401287951C.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 278,600,000 United States dollar | superseded | [clm_CB31EDBF8BBF](/claim/clm_CB31EDBF8BBF.md) - 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 83,400,000 United States dollar | superseded | [clm_92364A9BCAD5](/claim/clm_92364A9BCAD5.md) - 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 807,800,000 United States dollar | superseded | [clm_2C5BC5128C6D](/claim/clm_2C5BC5128C6D.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 5,644,600,000 United States dollar | superseded | [clm_364C70FCA279](/claim/clm_364C70FCA279.md) - 2017-09-30 to 2017-12-31 | money | total_equity | 4,957,900,000 United States dollar | superseded | [clm_B306657F81FE](/claim/clm_B306657F81FE.md) - 2017-10-17 to 2018-01-19 | money | shares_outstanding | 112,047,836 shares | superseded | [clm_207CF195059A](/claim/clm_207CF195059A.md) - 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 648,200,000 United States dollar | superseded | [clm_0C5109286F97](/claim/clm_0C5109286F97.md) - 2017-12-31 to 2018-12-31 | money | net_income | 660,000,000 United States dollar | superseded | [clm_96040591DAC7](/claim/clm_96040591DAC7.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 1,054,600,000 United States dollar | superseded | [clm_7152E6EEA77B](/claim/clm_7152E6EEA77B.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 328,600,000 United States dollar | superseded | [clm_E2F95A75CBDF](/claim/clm_E2F95A75CBDF.md) - 2017-12-31 to 2018-12-31 | money | revenue | 3,138,200,000 United States dollar | superseded | [clm_916C566A0981](/claim/clm_916C566A0981.md) - 2017-12-31 to 2018-03-31 | money | total_assets | 5,758,000,000 United States dollar | superseded | [clm_C3D24C07BDAA](/claim/clm_C3D24C07BDAA.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 4,725,200,000 United States dollar | superseded | [clm_DD485D449E07](/claim/clm_DD485D449E07.md) ## 2018 - 2018-01-19 to 2018-04-13 | money | shares_outstanding | 112,298,504 shares | superseded | [clm_09E5A86BCBC2](/claim/clm_09E5A86BCBC2.md) - 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 974,700,000 United States dollar | superseded | [clm_6FD79F771A07](/claim/clm_6FD79F771A07.md) - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 287,600,000 United States dollar | superseded | [clm_C20DB4DC46DB](/claim/clm_C20DB4DC46DB.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 276,700,000 United States dollar | superseded | [clm_705BC7871B48](/claim/clm_705BC7871B48.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 95,500,000 United States dollar | superseded | [clm_034989504909](/claim/clm_034989504909.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 847,500,000 United States dollar | superseded | [clm_699FC24C7425](/claim/clm_699FC24C7425.md) - 2018-03-31 to 2018-06-30 | money | total_assets | 6,426,200,000 United States dollar | superseded | [clm_DFCD2F0D2B5A](/claim/clm_DFCD2F0D2B5A.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 5,497,100,000 United States dollar | superseded | [clm_A2D5D12E7A0E](/claim/clm_A2D5D12E7A0E.md) - 2018-04-13 to 2018-07-17 | money | shares_outstanding | 113,295,092 shares | superseded | [clm_E686C997D442](/claim/clm_E686C997D442.md) - 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 1,203,500,000 United States dollar | superseded | [clm_144E62BFABF8](/claim/clm_144E62BFABF8.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 255,300,000 United States dollar | superseded | [clm_1D4405AD9CA9](/claim/clm_1D4405AD9CA9.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 277,400,000 United States dollar | superseded | [clm_7718D9B65BCA](/claim/clm_7718D9B65BCA.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 95,100,000 United States dollar | superseded | [clm_4EF01215080D](/claim/clm_4EF01215080D.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 909,300,000 United States dollar | superseded | [clm_04B6667E487D](/claim/clm_04B6667E487D.md) - 2018-06-30 to 2018-09-30 | money | total_assets | 6,849,600,000 United States dollar | superseded | [clm_DFD267211702](/claim/clm_DFD267211702.md) - 2018-06-30 to 2018-09-30 | money | total_equity | 5,860,600,000 United States dollar | superseded | [clm_E0E3D12E6D68](/claim/clm_E0E3D12E6D68.md) - 2018-07-17 to 2018-10-16 | money | shares_outstanding | 113,747,594 shares | superseded | [clm_A6F89FE7F071](/claim/clm_A6F89FE7F071.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 1,008,300,000 United States dollar | superseded | [clm_602A1BFAFAEC](/claim/clm_602A1BFAFAEC.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 292,500,000 United States dollar | superseded | [clm_F70DBA17E75E](/claim/clm_F70DBA17E75E.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 313,300,000 United States dollar | superseded | [clm_E4AC5BEAA376](/claim/clm_E4AC5BEAA376.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 107,600,000 United States dollar | superseded | [clm_2823D17AE9A0](/claim/clm_2823D17AE9A0.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 920,900,000 United States dollar | superseded | [clm_1ADD276443CA](/claim/clm_1ADD276443CA.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 7,318,600,000 United States dollar | superseded | [clm_513959B802F1](/claim/clm_513959B802F1.md) - 2018-09-30 to 2018-12-31 | money | total_equity | 6,280,600,000 United States dollar | superseded | [clm_436AB30B1521](/claim/clm_436AB30B1521.md) - 2018-10-16 to 2019-01-18 | money | shares_outstanding | 114,200,264 shares | superseded | [clm_3CCC7A1B8BE0](/claim/clm_3CCC7A1B8BE0.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 857,900,000 United States dollar | superseded | [clm_30D48EFA5403](/claim/clm_30D48EFA5403.md) - 2018-12-31 to 2019-12-31 | money | net_income | 1,127,900,000 United States dollar | superseded | [clm_27A6FB64DE39](/claim/clm_27A6FB64DE39.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 1,199,400,000 United States dollar | superseded | [clm_E691B927BB86](/claim/clm_E691B927BB86.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 418,100,000 United States dollar | superseded | [clm_66FFDAEE620B](/claim/clm_66FFDAEE620B.md) - 2018-12-31 to 2019-12-31 | money | revenue | 3,724,200,000 United States dollar | superseded | [clm_216A3669C41B](/claim/clm_216A3669C41B.md) - 2018-12-31 to 2019-03-31 | money | total_assets | 7,846,700,000 United States dollar | superseded | [clm_FB4A09149EEF](/claim/clm_FB4A09149EEF.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 6,678,800,000 United States dollar | superseded | [clm_4E60C7E9B817](/claim/clm_4E60C7E9B817.md) ## 2019 - 2019-01-18 to 2019-04-16 | money | shares_outstanding | 114,488,602 shares | superseded | [clm_DA45019251FB](/claim/clm_DA45019251FB.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 875,700,000 United States dollar | superseded | [clm_CD4BE6124C9A](/claim/clm_CD4BE6124C9A.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 306,500,000 United States dollar | superseded | [clm_AA269EE04A97](/claim/clm_AA269EE04A97.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 252,200,000 United States dollar | superseded | [clm_903C65385B02](/claim/clm_903C65385B02.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 144,000,000 United States dollar | superseded | [clm_730F9E0CDF39](/claim/clm_730F9E0CDF39.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 973,700,000 United States dollar | superseded | [clm_E06FF192BDC9](/claim/clm_E06FF192BDC9.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 8,234,900,000 United States dollar | superseded | [clm_1A3B2E53FAC5](/claim/clm_1A3B2E53FAC5.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 7,024,200,000 United States dollar | superseded | [clm_94BA01E7444E](/claim/clm_94BA01E7444E.md) - 2019-04-16 to 2019-07-16 | money | shares_outstanding | 115,448,658 shares | superseded | [clm_3B744C221F0B](/claim/clm_3B744C221F0B.md) - 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 790,300,000 United States dollar | superseded | [clm_50C0B909F91D](/claim/clm_50C0B909F91D.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 318,300,000 United States dollar | superseded | [clm_32C1787637FA](/claim/clm_32C1787637FA.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 359,000,000 United States dollar | superseded | [clm_1323076856D5](/claim/clm_1323076856D5.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 120,800,000 United States dollar | superseded | [clm_0AE4F1850DAF](/claim/clm_0AE4F1850DAF.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 1,098,900,000 United States dollar | superseded | [clm_FF926D539176](/claim/clm_FF926D539176.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 8,531,600,000 United States dollar | superseded | [clm_3F7DB2D090F4](/claim/clm_3F7DB2D090F4.md) - 2019-06-30 to 2019-09-30 | money | total_equity | 7,265,300,000 United States dollar | superseded | [clm_6A202229F1FC](/claim/clm_6A202229F1FC.md) - 2019-07-16 to 2019-10-15 | money | shares_outstanding | 115,253,433 shares | superseded | [clm_F53F447AB325](/claim/clm_F53F447AB325.md) - 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 969,600,000 United States dollar | superseded | [clm_BE911A8C21E9](/claim/clm_BE911A8C21E9.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 396,800,000 United States dollar | superseded | [clm_C2B035A5B866](/claim/clm_C2B035A5B866.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 365,700,000 United States dollar | superseded | [clm_E84051927D0A](/claim/clm_E84051927D0A.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 135,900,000 United States dollar | superseded | [clm_54052E9D4204](/claim/clm_54052E9D4204.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 1,128,200,000 United States dollar | superseded | [clm_342E72EC416E](/claim/clm_342E72EC416E.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 9,131,300,000 United States dollar | superseded | [clm_64C2E2ED1237](/claim/clm_64C2E2ED1237.md) - 2019-09-30 to 2019-12-31 | money | total_equity | 7,761,400,000 United States dollar | superseded | [clm_FA26F902F8C6](/claim/clm_FA26F902F8C6.md) - 2019-10-15 to 2020-01-17 | money | shares_outstanding | 115,573,505 shares | superseded | [clm_73517FCFB416](/claim/clm_73517FCFB416.md) - 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 1,167,600,000 United States dollar | superseded | [clm_AA68EF4B309D](/claim/clm_AA68EF4B309D.md) - 2019-12-31 to 2020-12-31 | money | net_income | 1,379,300,000 United States dollar | superseded | [clm_BF46912C8E57](/claim/clm_BF46912C8E57.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 1,374,500,000 United States dollar | superseded | [clm_A63B0DC03C34](/claim/clm_A63B0DC03C34.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 557,300,000 United States dollar | superseded | [clm_DEE28357B417](/claim/clm_DEE28357B417.md) - 2019-12-31 to 2020-12-31 | money | revenue | 4,478,500,000 United States dollar | superseded | [clm_9DCAD8DE721D](/claim/clm_9DCAD8DE721D.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 9,733,200,000 United States dollar | superseded | [clm_E3BE7B21156D](/claim/clm_E3BE7B21156D.md) - 2019-12-31 to 2020-03-31 | money | total_equity | 8,263,800,000 United States dollar | superseded | [clm_5E6F73A14A3D](/claim/clm_5E6F73A14A3D.md) ## 2020 - 2020-01-17 to 2020-04-14 | money | shares_outstanding | 115,984,044 shares | superseded | [clm_EF60233D89BE](/claim/clm_EF60233D89BE.md) - 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 1,223,800,000 United States dollar | superseded | [clm_15129369EEC1](/claim/clm_15129369EEC1.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 313,500,000 United States dollar | superseded | [clm_F2B4FD52A0CF](/claim/clm_F2B4FD52A0CF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 283,000,000 United States dollar | superseded | [clm_D8D76F353A84](/claim/clm_D8D76F353A84.md) - 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 147,100,000 United States dollar | superseded | [clm_32B17F4806AF](/claim/clm_32B17F4806AF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 1,099,500,000 United States dollar | superseded | [clm_A81A5D2474B8](/claim/clm_A81A5D2474B8.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 9,891,100,000 United States dollar | superseded | [clm_78CEB8873655](/claim/clm_78CEB8873655.md) - 2020-03-31 to 2020-06-30 | money | total_equity | 8,506,700,000 United States dollar | superseded | [clm_FB6CB39BD03B](/claim/clm_FB6CB39BD03B.md) - 2020-04-14 to 2020-07-20 | money | shares_outstanding | 116,617,784 shares | superseded | [clm_C4542604AE85](/claim/clm_C4542604AE85.md) - 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 2,035,600,000 United States dollar | superseded | [clm_3F764CCE8080](/claim/clm_3F764CCE8080.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 68,000,000 United States dollar | superseded | [clm_6AB43F8E88A0](/claim/clm_6AB43F8E88A0.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 80,600,000 United States dollar | superseded | [clm_2E3CE0C15132](/claim/clm_2E3CE0C15132.md) - 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 143,200,000 United States dollar | superseded | [clm_0835B81E57C4](/claim/clm_0835B81E57C4.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 852,100,000 United States dollar | superseded | [clm_F2CB51F08D93](/claim/clm_F2CB51F08D93.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 10,103,600,000 United States dollar | superseded | [clm_D22B2AEB8694](/claim/clm_D22B2AEB8694.md) - 2020-06-30 to 2020-09-30 | money | total_equity | 8,740,500,000 United States dollar | superseded | [clm_86B01A2D003A](/claim/clm_86B01A2D003A.md) - 2020-07-20 to 2020-10-14 | money | shares_outstanding | 117,025,880 shares | superseded | [clm_FFAB4C2F97F3](/claim/clm_FFAB4C2F97F3.md) - 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 1,370,600,000 United States dollar | superseded | [clm_4ACC53FC496C](/claim/clm_4ACC53FC496C.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 313,900,000 United States dollar | superseded | [clm_8DD968A18BDE](/claim/clm_8DD968A18BDE.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 270,400,000 United States dollar | superseded | [clm_2FC81FA4440F](/claim/clm_2FC81FA4440F.md) - 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 155,000,000 United States dollar | superseded | [clm_1BB3567C0F6C](/claim/clm_1BB3567C0F6C.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 1,077,700,000 United States dollar | superseded | [clm_2DE45B763C50](/claim/clm_2DE45B763C50.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 10,617,500,000 United States dollar | superseded | [clm_33A56E42898D](/claim/clm_33A56E42898D.md) - 2020-09-30 to 2020-12-31 | money | total_equity | 9,257,800,000 United States dollar | superseded | [clm_0C672F1C8CEB](/claim/clm_0C672F1C8CEB.md) - 2020-10-14 to 2021-01-15 | money | shares_outstanding | 117,555,484 shares | superseded | [clm_C91CB8B1F887](/claim/clm_C91CB8B1F887.md) - 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 1,622,600,000 United States dollar | superseded | [clm_15FD523153A5](/claim/clm_15FD523153A5.md) - 2020-12-31 to 2021-12-31 | money | net_income | 1,060,600,000 United States dollar | superseded | [clm_4F94C36E3A38](/claim/clm_4F94C36E3A38.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 1,049,800,000 United States dollar | superseded | [clm_8BAFEC7E2F6F](/claim/clm_8BAFEC7E2F6F.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 595,100,000 United States dollar | superseded | [clm_3F235DD9977E](/claim/clm_3F235DD9977E.md) - 2020-12-31 to 2021-12-31 | money | revenue | 4,358,400,000 United States dollar | superseded | [clm_02821EC07019](/claim/clm_02821EC07019.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 11,168,900,000 United States dollar | superseded | [clm_DE38590FEC9C](/claim/clm_DE38590FEC9C.md) - 2020-12-31 to 2021-03-31 | money | total_equity | 9,731,500,000 United States dollar | superseded | [clm_D59830CAB4EE](/claim/clm_D59830CAB4EE.md) ## 2021 - 2021-01-15 to 2021-04-16 | money | shares_outstanding | 117,718,298 shares | superseded | [clm_A826CAE7F12F](/claim/clm_A826CAE7F12F.md) - 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 1,401,800,000 United States dollar | superseded | [clm_B8D4A9D9BA8B](/claim/clm_B8D4A9D9BA8B.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 426,300,000 United States dollar | superseded | [clm_ADEE58DEDEFF](/claim/clm_ADEE58DEDEFF.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 416,800,000 United States dollar | superseded | [clm_ED26DBC975DD](/claim/clm_ED26DBC975DD.md) - 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 159,800,000 United States dollar | superseded | [clm_E8F0C106FD96](/claim/clm_E8F0C106FD96.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 1,292,100,000 United States dollar | superseded | [clm_8706685B1BB5](/claim/clm_8706685B1BB5.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 11,540,400,000 United States dollar | superseded | [clm_02243E31D99D](/claim/clm_02243E31D99D.md) - 2021-03-31 to 2021-06-30 | money | total_equity | 10,153,500,000 United States dollar | superseded | [clm_D6AD86DDD491](/claim/clm_D6AD86DDD491.md) - 2021-04-16 to 2021-07-15 | money | shares_outstanding | 118,412,888 shares | superseded | [clm_8E8B890BCFAB](/claim/clm_8E8B890BCFAB.md) - 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 1,615,500,000 United States dollar | superseded | [clm_AC20DBA39AC0](/claim/clm_AC20DBA39AC0.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 517,200,000 United States dollar | superseded | [clm_8D10EE6380B7](/claim/clm_8D10EE6380B7.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 511,200,000 United States dollar | superseded | [clm_466A9DAB65E5](/claim/clm_466A9DAB65E5.md) - 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 162,300,000 United States dollar | superseded | [clm_1D7925F90C68](/claim/clm_1D7925F90C68.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 1,464,000,000 United States dollar | superseded | [clm_B58C1E77BDC0](/claim/clm_B58C1E77BDC0.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 12,297,000,000 United States dollar | superseded | [clm_37E486AFB5F8](/claim/clm_37E486AFB5F8.md) - 2021-06-30 to 2021-09-30 | money | total_equity | 10,837,500,000 United States dollar | superseded | [clm_B9ED3CB14E7B](/claim/clm_B9ED3CB14E7B.md) - 2021-07-15 to 2021-10-14 | money | shares_outstanding | 118,747,607 shares | superseded | [clm_94ED1DA768C9](/claim/clm_94ED1DA768C9.md) - 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 1,346,700,000 United States dollar | superseded | [clm_69FE50627EF0](/claim/clm_69FE50627EF0.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 380,500,000 United States dollar | superseded | [clm_9E0D878FBEAA](/claim/clm_9E0D878FBEAA.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 442,600,000 United States dollar | superseded | [clm_F743D5012908](/claim/clm_F743D5012908.md) - 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 165,500,000 United States dollar | superseded | [clm_C911A0C2489E](/claim/clm_C911A0C2489E.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 1,403,300,000 United States dollar | superseded | [clm_876AC422FC17](/claim/clm_876AC422FC17.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 12,934,600,000 United States dollar | superseded | [clm_BDADCE7CA7FF](/claim/clm_BDADCE7CA7FF.md) - 2021-09-30 to 2021-12-31 | money | total_equity | 11,410,900,000 United States dollar | superseded | [clm_85048159742E](/claim/clm_85048159742E.md) - 2021-10-14 to 2022-01-26 | money | shares_outstanding | 357,236,861 shares | superseded | [clm_271FBEF18CD0](/claim/clm_271FBEF18CD0.md) - 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 1,290,900,000 United States dollar | superseded | [clm_E1BD1FDD3E44](/claim/clm_E1BD1FDD3E44.md) - 2021-12-31 to 2022-12-31 | money | net_income | 1,704,600,000 United States dollar | superseded | [clm_AC0DD4651AC3](/claim/clm_AC0DD4651AC3.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 1,821,000,000 United States dollar | superseded | [clm_BB331749DE10](/claim/clm_BB331749DE10.md) - 2021-12-31 to 2022-12-31 | money | research_and_development | 671,000,000 United States dollar | superseded | [clm_B3F25B35F7E1](/claim/clm_B3F25B35F7E1.md) - 2021-12-31 to 2022-12-31 | money | revenue | 5,710,100,000 United States dollar | superseded | [clm_2ABF64CBE119](/claim/clm_2ABF64CBE119.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 13,555,000,000 United States dollar | superseded | [clm_A8E8E3817023](/claim/clm_A8E8E3817023.md) - 2021-12-31 to 2022-03-31 | money | total_equity | 11,901,100,000 United States dollar | superseded | [clm_59A9D60D683C](/claim/clm_59A9D60D683C.md) ## 2022 - 2022-01-26 to 2022-04-19 | money | shares_outstanding | 357,744,031 shares | superseded | [clm_633C4956EADD](/claim/clm_633C4956EADD.md) - 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 1,103,100,000 United States dollar | superseded | [clm_9957511DB1B1](/claim/clm_9957511DB1B1.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 365,600,000 United States dollar | superseded | [clm_2673F830E33A](/claim/clm_2673F830E33A.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 408,100,000 United States dollar | superseded | [clm_C2940990E859](/claim/clm_C2940990E859.md) - 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 210,500,000 United States dollar | superseded | [clm_EB8F0180F50E](/claim/clm_EB8F0180F50E.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 1,487,700,000 United States dollar | superseded | [clm_F8B04E6DF4BE](/claim/clm_F8B04E6DF4BE.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 13,678,400,000 United States dollar | superseded | [clm_BF5D693C139C](/claim/clm_BF5D693C139C.md) - 2022-03-31 to 2022-06-30 | money | total_equity | 12,102,300,000 United States dollar | superseded | [clm_334ECBAC0B16](/claim/clm_334ECBAC0B16.md) - 2022-04-19 to 2022-07-19 | money | shares_outstanding | 358,956,511 shares | superseded | [clm_FE6EE4AFFC9C](/claim/clm_FE6EE4AFFC9C.md) - 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 1,536,100,000 United States dollar | superseded | [clm_F7FD24323ABD](/claim/clm_F7FD24323ABD.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 307,800,000 United States dollar | superseded | [clm_71AADABE3CBF](/claim/clm_71AADABE3CBF.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 397,600,000 United States dollar | superseded | [clm_9DEE1A516FA3](/claim/clm_9DEE1A516FA3.md) - 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 207,300,000 United States dollar | superseded | [clm_7DC51253EA28](/claim/clm_7DC51253EA28.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 1,522,100,000 United States dollar | superseded | [clm_6DB64A28426F](/claim/clm_6DB64A28426F.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 13,705,200,000 United States dollar | superseded | [clm_4146D322364F](/claim/clm_4146D322364F.md) - 2022-06-30 to 2022-09-30 | money | total_equity | 12,023,000,000 United States dollar | superseded | [clm_9DF137999102](/claim/clm_9DF137999102.md) - 2022-07-19 to 2022-10-18 | money | shares_outstanding | 357,111,192 shares | superseded | [clm_B82F1355B44F](/claim/clm_B82F1355B44F.md) - 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 1,538,000,000 United States dollar | superseded | [clm_6470FC1641E9](/claim/clm_6470FC1641E9.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 324,000,000 United States dollar | superseded | [clm_E7CFA06A7522](/claim/clm_E7CFA06A7522.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 398,900,000 United States dollar | superseded | [clm_E6FF85D5C1FD](/claim/clm_E6FF85D5C1FD.md) - 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 217,100,000 United States dollar | superseded | [clm_B968B0CAE9AE](/claim/clm_B968B0CAE9AE.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 1,557,400,000 United States dollar | superseded | [clm_549FA973C84F](/claim/clm_549FA973C84F.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 13,260,800,000 United States dollar | superseded | [clm_30C6632F0AE3](/claim/clm_30C6632F0AE3.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 11,515,400,000 United States dollar | superseded | [clm_015C1687B478](/claim/clm_015C1687B478.md) - 2022-10-18 to 2023-02-07 | money | shares_outstanding | 353,384,570 shares | superseded | [clm_5748844CF27A](/claim/clm_5748844CF27A.md) - 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 1,581,200,000 United States dollar | superseded | [clm_2E9391C52E13](/claim/clm_2E9391C52E13.md) - 2022-12-31 to 2023-12-31 | money | net_income | 1,322,300,000 United States dollar | superseded | [clm_6C06723FC5DD](/claim/clm_6C06723FC5DD.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 1,577,100,000 United States dollar | superseded | [clm_081572E6D816](/claim/clm_081572E6D816.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 879,000,000 United States dollar | superseded | [clm_01DDE3AF9061](/claim/clm_01DDE3AF9061.md) - 2022-12-31 to 2023-12-31 | money | revenue | 6,222,200,000 United States dollar | superseded | [clm_083A6C9BC82E](/claim/clm_083A6C9BC82E.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 12,974,000,000 United States dollar | superseded | [clm_A004488FC0A6](/claim/clm_A004488FC0A6.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 11,041,900,000 United States dollar | superseded | [clm_2A6AB494D318](/claim/clm_2A6AB494D318.md) ## 2023 - 2023-02-07 to 2023-04-17 | money | shares_outstanding | 350,389,679 shares | superseded | [clm_40DBC0C2D96B](/claim/clm_40DBC0C2D96B.md) - 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 2,143,000,000 United States dollar | superseded | [clm_1D63AE9080F8](/claim/clm_1D63AE9080F8.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 355,300,000 United States dollar | superseded | [clm_36F910B5B5F7](/claim/clm_36F910B5B5F7.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 387,600,000 United States dollar | superseded | [clm_26B670448BA8](/claim/clm_26B670448BA8.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 244,900,000 United States dollar | superseded | [clm_117B6CD9BA62](/claim/clm_117B6CD9BA62.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 1,696,200,000 United States dollar | superseded | [clm_BE731C7F7746](/claim/clm_BE731C7F7746.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 13,053,200,000 United States dollar | superseded | [clm_55ECEAB46AD2](/claim/clm_55ECEAB46AD2.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 11,217,700,000 United States dollar | superseded | [clm_C1A5970750A2](/claim/clm_C1A5970750A2.md) - 2023-04-17 to 2023-07-18 | money | shares_outstanding | 350,398,068 shares | superseded | [clm_3E924CF11C98](/claim/clm_3E924CF11C98.md) - 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 3,435,400,000 United States dollar | superseded | [clm_DE74B3D95D66](/claim/clm_DE74B3D95D66.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 420,800,000 United States dollar | superseded | [clm_72CEDF7C0466](/claim/clm_72CEDF7C0466.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 463,200,000 United States dollar | superseded | [clm_C4B811F789E2](/claim/clm_C4B811F789E2.md) - 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 244,400,000 United States dollar | superseded | [clm_1568441F1F24](/claim/clm_1568441F1F24.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 1,755,900,000 United States dollar | superseded | [clm_3CD848CA1B43](/claim/clm_3CD848CA1B43.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 13,903,300,000 United States dollar | superseded | [clm_CA750215A038](/claim/clm_CA750215A038.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 11,879,100,000 United States dollar | superseded | [clm_A97143CEC4B7](/claim/clm_A97143CEC4B7.md) - 2023-07-18 to 2023-10-16 | money | shares_outstanding | 351,354,675 shares | superseded | [clm_53FB46CD9F44](/claim/clm_53FB46CD9F44.md) - 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 3,602,000,000 United States dollar | superseded | [clm_E9C9A6C665C5](/claim/clm_E9C9A6C665C5.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 415,700,000 United States dollar | superseded | [clm_35AF4C9155E3](/claim/clm_35AF4C9155E3.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 465,800,000 United States dollar | superseded | [clm_EF9FE0650CB7](/claim/clm_EF9FE0650CB7.md) - 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 249,400,000 United States dollar | superseded | [clm_FC2C4AE457C8](/claim/clm_FC2C4AE457C8.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 1,743,700,000 United States dollar | superseded | [clm_D9F24093C0C2](/claim/clm_D9F24093C0C2.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 14,712,700,000 United States dollar | superseded | [clm_193748B8C7C7](/claim/clm_193748B8C7C7.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 12,539,000,000 United States dollar | superseded | [clm_31B18BAB08B9](/claim/clm_31B18BAB08B9.md) - 2023-10-16 to 2024-01-25 | money | shares_outstanding | 352,071,592 shares | superseded | [clm_AB7D3ACD0821](/claim/clm_AB7D3ACD0821.md) - 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 2,750,100,000 United States dollar | superseded | [clm_35010CCB3047](/claim/clm_35010CCB3047.md) - 2023-12-31 to 2024-12-31 | money | net_income | 1,798,000,000 United States dollar | superseded | [clm_B1EF17D02E1D](/claim/clm_B1EF17D02E1D.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 1,766,800,000 United States dollar | superseded | [clm_1CFA1F52B08C](/claim/clm_1CFA1F52B08C.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 998,800,000 United States dollar | superseded | [clm_C673B2B44A8B](/claim/clm_C673B2B44A8B.md) - 2023-12-31 to 2024-12-31 | money | revenue | 7,124,100,000 United States dollar | superseded | [clm_5BF0096BCC35](/claim/clm_5BF0096BCC35.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 15,441,500,000 United States dollar | superseded | [clm_D6154545504C](/claim/clm_D6154545504C.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 13,307,600,000 United States dollar | superseded | [clm_17D7074E9797](/claim/clm_17D7074E9797.md) ## 2024 - 2024-01-25 to 2024-04-15 | money | shares_outstanding | 352,325,863 shares | superseded | [clm_A6C0A8DA768B](/claim/clm_A6C0A8DA768B.md) - 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 2,839,500,000 United States dollar | superseded | [clm_7D22FBABA911](/claim/clm_7D22FBABA911.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 544,900,000 United States dollar | superseded | [clm_8C44E7EC70E9](/claim/clm_8C44E7EC70E9.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 469,400,000 United States dollar | superseded | [clm_429523A13E6C](/claim/clm_429523A13E6C.md) - 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 284,500,000 United States dollar | superseded | [clm_A7BC46A24240](/claim/clm_A7BC46A24240.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 1,890,600,000 United States dollar | superseded | [clm_61BB0AF463F0](/claim/clm_61BB0AF463F0.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 15,828,000,000 United States dollar | superseded | [clm_2BDC9FA45EDD](/claim/clm_2BDC9FA45EDD.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 13,962,600,000 United States dollar | superseded | [clm_BCF5EDCFD553](/claim/clm_BCF5EDCFD553.md) - 2024-04-15 to 2024-07-16 | money | shares_outstanding | 354,705,822 shares | superseded | [clm_68BE10ABF5BD](/claim/clm_68BE10ABF5BD.md) - 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 3,036,700,000 United States dollar | superseded | [clm_FADE75DC6C39](/claim/clm_FADE75DC6C39.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 526,900,000 United States dollar | superseded | [clm_A183B5BCE1F9](/claim/clm_A183B5BCE1F9.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 567,300,000 United States dollar | superseded | [clm_FDCA5889C82D](/claim/clm_FDCA5889C82D.md) - 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 280,100,000 United States dollar | superseded | [clm_476585ED7DE3](/claim/clm_476585ED7DE3.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 2,009,900,000 United States dollar | superseded | [clm_434453DA1D8D](/claim/clm_434453DA1D8D.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 16,649,900,000 United States dollar | superseded | [clm_00190D65823D](/claim/clm_00190D65823D.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 14,708,300,000 United States dollar | superseded | [clm_F18532B91610](/claim/clm_F18532B91610.md) - 2024-07-16 to 2024-10-15 | money | shares_outstanding | 355,354,176 shares | superseded | [clm_4609AD0DFE04](/claim/clm_4609AD0DFE04.md) - 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 2,413,300,000 United States dollar | superseded | [clm_4134EEFF001F](/claim/clm_4134EEFF001F.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 565,100,000 United States dollar | superseded | [clm_F3C30ADE58C4](/claim/clm_F3C30ADE58C4.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 577,300,000 United States dollar | superseded | [clm_DE2537D3B368](/claim/clm_DE2537D3B368.md) - 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 286,000,000 United States dollar | superseded | [clm_81D32B57D0E2](/claim/clm_81D32B57D0E2.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 2,038,100,000 United States dollar | superseded | [clm_C25C550CD671](/claim/clm_C25C550CD671.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 17,743,400,000 United States dollar | superseded | [clm_C88F42A4F27E](/claim/clm_C88F42A4F27E.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 15,583,300,000 United States dollar | superseded | [clm_FA4722A33566](/claim/clm_FA4722A33566.md) - 2024-10-15 to 2025-01-27 | money | shares_outstanding | 356,179,445 shares | superseded | [clm_6AC6E0B928B1](/claim/clm_6AC6E0B928B1.md) - 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 2,027,400,000 United States dollar | superseded | [clm_BDFEBCF86FBA](/claim/clm_BDFEBCF86FBA.md) - 2024-12-31 to 2025-12-31 | money | net_income | 2,322,600,000 United States dollar | superseded | [clm_D037E9567833](/claim/clm_D037E9567833.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 2,348,900,000 United States dollar | superseded | [clm_F8FF4087AAFD](/claim/clm_F8FF4087AAFD.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 1,145,300,000 United States dollar | superseded | [clm_058853AB6DD5](/claim/clm_058853AB6DD5.md) - 2024-12-31 to 2025-12-31 | money | revenue | 8,352,100,000 United States dollar | superseded | [clm_31BDE204C902](/claim/clm_31BDE204C902.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 18,743,200,000 United States dollar | superseded | [clm_8FD5C508A497](/claim/clm_8FD5C508A497.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 16,433,700,000 United States dollar | superseded | [clm_3CE649B8ABF8](/claim/clm_3CE649B8ABF8.md) ## 2025 - 2025-01-27 to 2025-04-15 | money | shares_outstanding | 356,656,964 shares | superseded | [clm_19A38EF24A16](/claim/clm_19A38EF24A16.md) - 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 2,573,800,000 United States dollar | superseded | [clm_69FAA6D95D36](/claim/clm_69FAA6D95D36.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 698,400,000 United States dollar | superseded | [clm_EDE18979D4C8](/claim/clm_EDE18979D4C8.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 578,100,000 United States dollar | superseded | [clm_A64BFE406C2B](/claim/clm_A64BFE406C2B.md) - 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 316,200,000 United States dollar | superseded | [clm_0978860DCCDC](/claim/clm_0978860DCCDC.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 2,253,400,000 United States dollar | superseded | [clm_E99503ECE379](/claim/clm_E99503ECE379.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 19,220,400,000 United States dollar | superseded | [clm_273D284AED2C](/claim/clm_273D284AED2C.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 17,106,400,000 United States dollar | superseded | [clm_D3DD53BBF9B6](/claim/clm_D3DD53BBF9B6.md) - 2025-04-15 to 2025-07-17 | money | shares_outstanding | 358,418,255 shares | superseded | [clm_EB5B41D0F8CC](/claim/clm_EB5B41D0F8CC.md) - 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 3,403,100,000 United States dollar | superseded | [clm_2BF05C7D8E38](/claim/clm_2BF05C7D8E38.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 658,400,000 United States dollar | superseded | [clm_A89D5D4EFCDA](/claim/clm_A89D5D4EFCDA.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 743,400,000 United States dollar | superseded | [clm_7B83B2AA9550](/claim/clm_7B83B2AA9550.md) - 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 313,300,000 United States dollar | superseded | [clm_3738B5C770E0](/claim/clm_3738B5C770E0.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 2,440,000,000 United States dollar | superseded | [clm_8D14A8E05AC5](/claim/clm_8D14A8E05AC5.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 20,163,200,000 United States dollar | superseded | [clm_39EEA4147829](/claim/clm_39EEA4147829.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 17,845,700,000 United States dollar | superseded | [clm_E2223C499CE2](/claim/clm_E2223C499CE2.md) - 2025-07-17 to 2025-10-16 | money | shares_outstanding | 358,476,506 shares | superseded | [clm_BFFD5A240D52](/claim/clm_BFFD5A240D52.md) - 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 2,806,600,000 United States dollar | superseded | [clm_C8C5679E8998](/claim/clm_C8C5679E8998.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 704,400,000 United States dollar | superseded | [clm_2210EF769577](/claim/clm_2210EF769577.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 759,700,000 United States dollar | superseded | [clm_F4210E9B4A7F](/claim/clm_F4210E9B4A7F.md) - 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 329,400,000 United States dollar | superseded | [clm_DF66EDFAB263](/claim/clm_DF66EDFAB263.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 2,505,100,000 United States dollar | superseded | [clm_7178C5B3ECFB](/claim/clm_7178C5B3ECFB.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 19,351,800,000 United States dollar | superseded | [clm_3D283A56199E](/claim/clm_3D283A56199E.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 16,929,700,000 United States dollar | superseded | [clm_853CBAD11448](/claim/clm_853CBAD11448.md) - 2025-10-16 to 2026-01-28 | money | shares_outstanding | 354,496,073 shares | superseded | [clm_157E75201A8D](/claim/clm_157E75201A8D.md) - 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 3,368,000,000 United States dollar | superseded | [clm_162C7DD4E5E7](/claim/clm_162C7DD4E5E7.md) - 2025-12-31 | money | net_income | 2,856,000,000 United States dollar | valid | [clm_4D0E25A0F96D](/claim/clm_4D0E25A0F96D.md) - 2025-12-31 | money | operating_income | 2,945,500,000 United States dollar | valid | [clm_2D641B283CF6](/claim/clm_2D641B283CF6.md) - 2025-12-31 | money | research_and_development | 1,311,800,000 United States dollar | valid | [clm_4FD7118879B7](/claim/clm_4FD7118879B7.md) - 2025-12-31 | money | revenue | 10,064,700,000 United States dollar | valid | [clm_EFDF7B07AFD6](/claim/clm_EFDF7B07AFD6.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 20,458,700,000 United States dollar | superseded | [clm_ED20EC2C2C46](/claim/clm_ED20EC2C2C46.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 17,824,000,000 United States dollar | superseded | [clm_C7E73A8682EC](/claim/clm_C7E73A8682EC.md) ## 2026 - 2026-01-28 to 2026-04-15 | money | shares_outstanding | 355,130,237 shares | superseded | [clm_81D240849BBD](/claim/clm_81D240849BBD.md) - 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 2,006,500,000 United States dollar | superseded | [clm_C66920FFB83E](/claim/clm_C66920FFB83E.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 821,500,000 United States dollar | superseded | [clm_2729F2D41402](/claim/clm_2729F2D41402.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 855,300,000 United States dollar | superseded | [clm_2CAA1F578B21](/claim/clm_2CAA1F578B21.md) - 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 361,900,000 United States dollar | superseded | [clm_6BF2BD993B02](/claim/clm_6BF2BD993B02.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 2,770,800,000 United States dollar | superseded | [clm_16ECF4983752](/claim/clm_16ECF4983752.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 20,111,000,000 United States dollar | superseded | [clm_F31F83AEBDA8](/claim/clm_F31F83AEBDA8.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 17,474,500,000 United States dollar | superseded | [clm_DDD5BE584BBB](/claim/clm_DDD5BE584BBB.md) - 2026-04-15 to 2026-07-16 | money | shares_outstanding | 354,162,842 shares | superseded | [clm_6371A53C80B3](/claim/clm_6371A53C80B3.md) - 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 2,760,400,000 United States dollar | superseded | [clm_1D44FF055DC3](/claim/clm_1D44FF055DC3.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 818,100,000 United States dollar | superseded | [clm_16DB8514A17F](/claim/clm_16DB8514A17F.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 971,900,000 United States dollar | superseded | [clm_5D31CEC5ED35](/claim/clm_5D31CEC5ED35.md) - 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 370,600,000 United States dollar | superseded | [clm_580EE801171A](/claim/clm_580EE801171A.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 2,892,300,000 United States dollar | superseded | [clm_4D5093A3D663](/claim/clm_4D5093A3D663.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 20,876,600,000 United States dollar | superseded | [clm_85D58B44D88F](/claim/clm_85D58B44D88F.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 18,168,400,000 United States dollar | superseded | [clm_591267E794DF](/claim/clm_591267E794DF.md) - 2026-07-16 to 2026-10-15 | money | shares_outstanding | 353,278,038 shares | superseded | [clm_773661F1D4ED](/claim/clm_773661F1D4ED.md) - 2026-09-30 | money | cash_and_equivalents | 2,978,100,000 United States dollar | valid | [clm_B0395B58B4AF](/claim/clm_B0395B58B4AF.md) - 2026-09-30 | money | quarterly_net_income | 522,800,000 United States dollar | valid | [clm_AA7B0BF5D764](/claim/clm_AA7B0BF5D764.md) - 2026-09-30 | money | quarterly_operating_income | 592,600,000 United States dollar | valid | [clm_BDF3583AB18F](/claim/clm_BDF3583AB18F.md) - 2026-09-30 | money | quarterly_research_and_development | 408,300,000 United States dollar | valid | [clm_92C490313BF8](/claim/clm_92C490313BF8.md) - 2026-09-30 | money | quarterly_revenue | 3,048,700,000 United States dollar | valid | [clm_E2C4559E07EF](/claim/clm_E2C4559E07EF.md) - 2026-09-30 | money | total_assets | 19,349,100,000 United States dollar | valid | [clm_002A77C5CE1B](/claim/clm_002A77C5CE1B.md) - 2026-09-30 | money | total_equity | 15,986,200,000 United States dollar | valid | [clm_49D2BFCFD295](/claim/clm_49D2BFCFD295.md) - 2026-10-15 | money | shares_outstanding | 346,643,718 shares | valid | [clm_E68405B65E72](/claim/clm_E68405B65E72.md) ## undated - undated | people | ceo | David J. Rosa | valid | [clm_4BA85C649653](/claim/clm_4BA85C649653.md) - undated | other | cik | 0001035267 | valid | [clm_A836C3DDF8E8](/claim/clm_A836C3DDF8E8.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_1440435577E1](/claim/clm_1440435577E1.md) - undated | other | headquarters | Sunnyvale | valid | [clm_DE5F5C3E9DE0](/claim/clm_DE5F5C3E9DE0.md) - undated | other | listed_on | Nasdaq | valid | [clm_AA7C73EC28B9](/claim/clm_AA7C73EC28B9.md) - undated | other | registrant_name | INTUITIVE SURGICAL INC | valid | [clm_6129D0B843B0](/claim/clm_6129D0B843B0.md) - undated | other | sic_industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | valid | [clm_1AC7C63C0E96](/claim/clm_1AC7C63C0E96.md) - undated | other | state_of_incorporation | DE | valid | [clm_E9D0037B7DD8](/claim/clm_E9D0037B7DD8.md) - undated | other | ticker | ISRG | valid | [clm_B0CA2EB48181](/claim/clm_B0CA2EB48181.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.